Now Available On-Demand - From Insight to Action: Integrating Cell-Free DNA Testing into Daily Transplant Care

Published 31 March 2026
  • Advanced Heart Failure & Transplantation
  • Advanced Lung Failure & Transplantation
  • Education
  • Industry
  • Industry Webinars
  • Mechanical Circulatory Support
  • News
  • Online Education
  • Past Industry Webinars
  • Virtual Event
  • Webinar

The webinar “From Insight to Action: Integrating Cell-Free DNA Testing into Daily Transplant Care”, presented by Natera, features leading voices in transplantation for a dynamic discussion on cell-free DNA (cfDNA) technology.

The expanded use of cfDNA technology in transplant medicine has transformed longstanding surveillance methods, as well as offered new insights into allograft health. This webinar provides a review of how cfDNA testing has changed the future of transplant surveillance and explores practical strategies for integrating cfDNA testing into transplant coordinators’ daily care.

Stream it Online

Topics included:

  • Review the fundamentals of cell-free DNA technology and the integration of ProsperaTM into post-transplant surveillance workflows.
  • Discover how Natera’s teams enhance existing clinical workflows through real-world examples, so transplant teams can focus on patient care.
  • Hear firsthand experiences from transplant coordinators detailing how partnering with Natera has measurably improved efficiency, communication, and workflow coordination.

WEBINAR SPEAKERS:

Megan Wall, BSN, RN
Clinical Nurse Coordinator – Thoracic
Natera
Pittsburgh, PA USA

 

 

Mitchell C. Li, AGPCNP-BC, NE-BC
Supervisor, Advanced Clinical Providers
Northwell Lung Transplant Institute
Manhasset, NY USA

 

 

Stream it Online

The content of this recording was developed entirely by our industry partner, Natera. It is not an official educational program of the ISHLT, and therefore is not eligible for CME under the ISHLT.